Table 2.
Comparison of blood pressure change after intervention among the two groups and within each group
| Spironolactone (n = 9) | Alternative drug regimen (n = 8) | P value | |
|---|---|---|---|
| Office blood pressure | |||
| SBP(mmHg) | |||
| Before | 158 (17) | 158 (8) | 0.96 |
| After | 125 (11) | 144 (17) | 0.02 |
| p value | 0.01 | 0.08 | |
| DBP(mmHg) | |||
| Before | 86 (11) | 94 (8) | 0.08 |
| After | 72 (8) | 89 (12) | 0.01 |
| p value | 0.01 | 0.02 | |
| Self-blood pressure measurement | |||
| SBP(mmHg) | |||
| Before | 140 (9) | 151 (15) | 0.06 |
| After | 123 (10) | 142 (14) | 0.01 |
| p value | 0.02 | 0.02 | |
| DBP(mmHg) | |||
| Before | 78 (8) | 91 (15) | 0.07 |
| After | 73 (7) | 86 (14) | 0.04 |
| p value | 0.11 | 0.09 | |
Data are expressed as means (standard deviations)
SBP systolic blood pressure; DBP diastolic blood pressure